Holen Sie sich die Stockscreener-App
1.69
3.14%
-0.06
Finanzdaten der Milestone Pharmaceuticals Inc-Aktie (MIST)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
7.39%
3.94
|
3.669 | 4.978 | 3.94 | 3.963 |
| Operating Income/Loss |
5.60%
-11.83
|
-12.53 | -20.52 | -12.35 | -9.616 |
| Income/Loss From Continuing Operations Before Tax |
8.05%
-11.92
|
-12.97 | -20.76 | -12.36 | -9.439 |
| Income/Loss From Continuing Operations After Tax |
8.05%
-11.92
|
-12.97 | -20.76 | -12.36 | -9.439 |
Net Income/Loss
|
8.05%
-11.92
|
-12.97 | -20.76 | -12.36 | -9.439 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
40.00%
-0.12
|
-0.20 | -0.31 | -0.19 | -0.14 |
| Diluted Earnings Per Share |
40.00%
-0.12
|
-0.20 | -0.31 | -0.19 | -0.14 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):